Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Heesu Nam 2 Articles
Lung and Thoracic cancer
Psychometric Validation of the Korean Version of the Cancer Survivors’ Unmet Needs (CaSUN) Scale among Korean Non–Small Cell Lung Cancer Survivors
Danbee Kang, Genehee Lee, Sooyeon Kim, Heesu Nam, Sunga Kong, Sungkeun Shim, Jae Kyung Lee, Wonyoung Jung, Sumin Shin, Hong Kwan Kim, Jae Ill Zo, Young Mog Shim, Dong Wook Shin, Juhee Cho
Cancer Res Treat. 2023;55(1):61-72.   Published online February 23, 2022
DOI: https://doi.org/10.4143/crt.2021.1583
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of the study was to validate the Korean version of Cancer Survivors’ Unmet Needs (CaSUN) scale among non–small cell lung cancer survivors.
Materials and Methods
Participants were recruited from outpatient clinics at the Samsung Medical Center in Seoul, South Korea, from January to October 2020. Participants completed a survey questionnaire that included the CaSUN. Exploratory and confirmatory factor analysis and Pearson’s correlations were used to evaluate the reliability and validity of the Korean version of the CaSUN (CaSUN-K). We also tested known-group validity using an independent t test or ANOVA.
Results
In total, 949 provided informed consent and all of which completed the questionnaire. Among the 949 patients, 529 (55.7%) were male; the mean age and median time since the end of active treatment (standard deviation) was 63.4±8.8 years and the median was 18 months. Although the factor loadings were different from those for the original scale, the Cronbach’s alpha coefficients of the six domains in the CaSUN-K ranged from 0.68 to 0.95, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the CaSUN-K were high. Moderate correlations demonstrated the convergent validity of CaSUN-K with the relevant questionnaire. More than 60% of the participants reported information-related unmet needs, and the CaSUN-K discriminated between the needs reported by the different subgroups that we analyzed.
Conclusion
The CaSUN-K is a reliable and valid measure for assessing the unmet needs in a cancer population, thus this tool help population to receive timely, targeted, and relevant care.

Citations

Citations to this article as recorded by  
  • Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial
    Wonyoung Jung, Alice Ahn, Genehee Lee, Sunga Kong, Danbee Kang, Dongok Lee, Tae Eun Kim, Young Mog Shim, Hong Kwan Kim, Jongho Cho, Juhee Cho, Dong Wook Shin
    JMIR Research Protocols.2024; 13: e54707.     CrossRef
  • Validity and Reliability of a Simplified Chinese Version of Cancer Survivors' Unmet Needs Scale (CaSUN)
    Xiaojingyuan Xu, Xiaoyun Liang, Shiquan Yin
    Psycho-Oncology.2024;[Epub]     CrossRef
  • Unmet Supportive Care Needs after Non-Small Cell Lung Cancer Resection at a Tertiary Hospital in Seoul, South Korea
    Junhee Park, Wonyoung Jung, Genehee Lee, Danbee Kang, Young Mog Shim, Hong Kwan Kim, Ansuk Jeong, Juhee Cho, Dong Wook Shin
    Healthcare.2023; 11(14): 2012.     CrossRef
  • Kanserden Kurtulanların Karşılanmayan İhtiyaçları Ölçeğinin Türkçeye Uyarlanması: Geçerlik ve Güvenirlik Çalışması
    Gülyeter Erdoğan Yüce, Gamze Muz, Ayser Döner
    Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi.2023; 10(3): 264.     CrossRef
  • Psychometric properties of the Slovenian version of the Cancer Survivors’ Unmet Needs (CaSUN-SL) measure in post-treatment cancer survivors
    Špela Miroševič, Polona Selič-Zupančič, Judith Prins, Vesna Homar, Zalika Klemenc-Ketiš
    BMC Psychology.2022;[Epub]     CrossRef
  • 5,862 View
  • 166 Download
  • 4 Web of Science
  • 5 Crossref
Close layer
General
Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors
Danbee Kang, Youngha Kim, Jihyun Lim, Junghee Yoon, Sooyeon Kim, Eunjee Kang, Heesu Nam, Sungkeun Shim, Mangyeong Lee, Haesook Bok, Sang-Won Lee, Soo-Yong Shin, Jin Seok Ahn, Dongryul Oh, Juhee Cho
Cancer Res Treat. 2022;54(1):10-19.   Published online April 9, 2021
DOI: https://doi.org/10.4143/crt.2020.1200
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors.
Materials and Methods
Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson’s correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1.
Results
The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach’s alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73).
Conclusion
The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.

Citations

Citations to this article as recorded by  
  • Path analysis of illness uncertainty and psychosocial adaptation of patients with Marfan syndrome
    Sujin Kim, Yeonsoo Jang, JiYeon Choi, Kijun Song, Jae-kwan Song, Mona Choi
    European Journal of Cardiovascular Nursing.2024; 23(2): 197.     CrossRef
  • A single-armed proof-of-concept study of Lymfit: A personalized, virtual exercise intervention to improve health outcomes in lymphoma survivors in the pandemic
    Christopher Angelillo, Wing Lam Tock, Matthew Salaciak, Ryan E. R. Reid, Ross E. Andersen, Christine Maheu, Nathalie A. Johnson, Miquel Vall-llosera Camps
    PLOS ONE.2024; 19(1): e0275038.     CrossRef
  • Psychometric validation of the Functional Assessment of Cancer Therapy‐Endometrial among endometrial cancer patients
    Sooyeon Kim, Joseph J. Noh, Youngha Kim, Juhee Cho, Danbee Kang, Yoo‐Young Lee
    Cancer Medicine.2024;[Epub]     CrossRef
  • Hungarian PROMIS-29+2: psychometric properties and population reference values
    Balázs Jenei, Alex Bató, Ariel Z. Mitev, Valentin Brodszky, Fanni Rencz
    Quality of Life Research.2023; 32(8): 2179.     CrossRef
  • Preliminary evaluation of the Chinese version of the patient-reported outcomes measurement information system 29-item profile in patients with aortic dissection
    Wanbing Huang, Qiansheng Wu, Yufen Zhang, Chong Tian, Haishan Huang, Sufang Huang, Yanrong Zhou, Jing He, Hui Wang
    Health and Quality of Life Outcomes.2022;[Epub]     CrossRef
  • Psychometric validation of the Korean version of PROMIS 29 Profile V2.1 among patients with lower extremity problems
    Youngha Kim, Danbee Kang, Eunjee Kang, Jihyun Lim, Sooyeon Kim, Heesu Nam, Sungkeun Shim, Mangyeong Lee, Young-Wan Moon, Seung-Jae Lim, Ki-Sun Sung, Juhee Cho
    BMC Sports Science, Medicine and Rehabilitation.2021;[Epub]     CrossRef
  • 7,810 View
  • 249 Download
  • 7 Web of Science
  • 6 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP